GLUCAGON (glucagon) by Fresenius Kabi is stomach, small bowel, and colon. First approved in 2015.
Drug data last refreshed 16h ago · AI intelligence enriched 2mo ago
Glucagon is a powder formulation of the glucagon hormone administered via intramuscular, intravenous, or subcutaneous injection. It is used to treat severe hypoglycemia in diabetic patients by stimulating the liver to release stored glucose. The drug works by binding to glucagon receptors in the stomach, small bowel, and colon to mobilize glucose stores.
Product is at peak commercial maturity with moderate competitive pressure; commercial teams are focused on market retention and managed care negotiations.
stomach, small bowel, and colon.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)
A Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapy
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1 Agonist
Glucagon Resistance in Patients With MASLD and T2DM
Worked on GLUCAGON at Fresenius Kabi? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on Glucagon offers exposure to an established, stable brand in the critical care/emergency treatment space, with career focus on defending market position and managing payer relationships. This role provides solid experience in specialty pharmaceutical commercialization but limited opportunity for new product launches or clinical pipeline development.